Headquartered in Secaucus, NJ Fiscal year ends December NYSE: DGX questdiagnostics.com
Quest Diagnostics Incorporated is a provider of diagnostic information services in the United States. The company offers a broad range of clinical laboratory testing services used by physicians, hospitals, and consumers to guide healthcare decisions including diagnosis, treatment, and prevention of disease. Quest serves approximately half of the physicians and hospitals in the United States and roughly one in three adult Americans each year, employing nearly 60,000 people. Its services span traditional clinical lab testing, advanced diagnostics including Alzheimer's disease blood testing (AD-Detect), and direct-to-consumer wellness testing. The company operates through its Diagnostic Information Services segment and is advancing technology initiatives including automation, AI-driven productivity improvements, and an Epic-based lab information system (Project Nova). Quest also pursues growth through acquisitions, health system partnerships via its Co-Lab Solutions program, and consumer health integrations such as its partnership with Apple Health. Updated
Requisition volume jumped 14.5%, enough to overpower a 4.2% decline in revenue per requisition and push the quarter past estimates on both lines. Management responded by raising full-year adjusted EPS guidance to $11.25-$11.35 and lifting operating cash flow to roughly $1.90 billion. Volume is carrying this story.
Wednesday's top analyst upgrades and downgrades included Annaly Capital Management, Capri, Chegg, Coinbase Global, CrowdStrike, Dell Technologies, Fortinet, HP, Kohl's, Palo Alto Networks, Penn Entertainment, Shoals Technologies, SoFi Technologies and ZScaler.
Tuesday's top analyst upgrades and downgrades included Agnico Eagle Mines, Bloom Energy, Crocs, Edison International, Enphase Energy, First Solar, Intel, Macy’s, Plug Power, SL Green Realty, Tesla and Wolfspeed.
Thursday’s additional top analyst upgrades and downgrades were on Advance Auto Parts, AppLovin, Nio, Norfolk Southern, Norwegian Cruise Line, Quest Diagnostics, Salesforce, Sprouts Farmers Market, Target, Workday and more.
Monday's additional top analyst upgrades and downgrades were on Canadian National Railway, Cardinal Health, Coupa Software, DocuSign, Gritstone Bio, United Parcel Service and more.
Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Danaher, DoorDash, Freeport-McMoRan, Gap, Gilead Sciences, Huntington Bancshares, Independence Realty Trust, Intuitive Surgical, KeyCorp, Marvell Technology, McDonald's, Medical Properties Trust, Nucor, PayPal,…
These five Buy-rated stocks in various sectors not only come with solid and dependable dividends but also offer a reasonably safe place for conservative growth and income investors to move capital to…
Tuesday's top analyst upgrades and downgrades included Analog Devices, Baxter, BorgWarner, Caesars Entertainment, CarMax, Chevron, Hertz Global, Li Auto, Starbucks, Tesla and Twitter.
Monday’s additional top analyst upgrades and downgrades included Blend Labs, Crocs, Gold Fields, Hologic, Leslie’s, Ollie’s Bargain Outlet, Quest Diagnostics and Welltower.
Wednesday afternoon's top analyst upgrades and downgrades included Altice USA, Dollar Tree, Macy’s, Marathon Oil and Star Bulk Carriers.
Given Warren Buffet's proclivity for only owning stock of companies that he understands inside and out, these 10 top health care picks with big, dependable dividends make sense now for growth and…
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Beyond Meat, Colgate-Palmolive, Edwards Lifesciences, Electronic Arts, Exxon Mobil, Meta Platforms, PayPal and Starbucks.
Wednesday afternoon's top analyst upgrades and downgrades included Advanced Micro Devices, Clorox, Clover Health Investments, Datadog, Electronic Arts, Etsy, General Motors, Intuitive Surgical, Starbucks and Under Armour.
Monday's top analyst upgrades and downgrades included Advance Auto Parts, Agnico-Eagle Mines, Applovin, ChargePoint, Corning, General Dynamics, QuantumScape, STMicroelectronics, Tapestry, Target and Williams-Sonoma.
Tuesday's top analyst upgrades and downgrades included Alphabet, Bank of America, Boeing, Coinbase, Dollar General, Kroger and McDonald's.
Friday's top analyst upgrades and downgrades included AerCap, Barclays, Denny's, DocuSign, Intercontinental Hotels, Lennar, Luminar Technologies and Quest Diagnostics.
Quest Diagnostics Incorporated is a provider of diagnostic information services in the United States. The company offers a broad range of clinical laboratory testing services used by physicians, hospitals, and consumers to guide healthcare decisions including diagnosis, treatment, and prevention of disease.
24/7 Wall St.'s 12-month price target for DGX is $293.83, rated Buy. The Wall Street consensus target is $254.73. DGX price prediction →
